Search Press releases Keywords From To 9 Oct 2015 Acquisition of own shares (October 9, 2015) Read More 8 Oct 2015 UCB presenting data on osteoporosis and romosozumab at 2015 American Society for Bone and Mineral Research (ASBMR) Annual Meeting Read More 8 Oct 2015 UCB with positive results for Vimpat® (lacosamide) in EU Phase 3 monotherapy study Read More 4 Sep 2015 UCB’s strong presence at International Epilepsy Congress reinforces value to epilepsy patients Read More 2 Sep 2015 UCB to sell its U.S. specialty generics business Kremers Urban to Lannett for US$ 1.23 billion in cash plus contingent payments Read More 1 Sep 2015 UCB and Amgen announce positive top-line results from open-label study of romosozumab compared with Teriparatide Read More Pagination First page Previous page Previous … Page 95 Page 96 Page 97 Page 98 Current page 99 Page 100 Page 101 Page 102 Page 103 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
